skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Assignor Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Assignor Name : DSM PHARMA CHEMICALS NORTH AMERICA, INC.
Total Assignments: 3
Assignment: 1
Reel/Frame:018480/0025   Pages: 4
Recorded: 11/03/2006
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor
1
Exec Dt:
09/29/2006
Assignee
1
451 FLORIDA STREET
BATON ROUGE, LOUISIANA 70801-1765
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
NONE
08749318
Correspondence name and address
ALBEMARLE CORPORATION
451 FLORIDA STREET
BATON ROUGE, LA 70801-1765
Assignment: 2
Reel/Frame:032403/0554   Pages: 7
Recorded: 03/11/2014
Attorney Dkt #:78442.00082
Conveyance: SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor
1
Exec Dt:
03/11/2014
Assignee
1
677 WASHINGTON BOULEVARD, 6TH FLOOR
STAMFORD, CONNECTICUT 06901
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
NONE
09260640
Correspondence name and address
CHRISTINE DIONNE C/O PAUL HASTINGS LLP
75 EAST 55TH STREET
NEW YORK, NY 10022
Assignment: 3
Reel/Frame:053519/0722   Pages: 4
Recorded: 08/17/2020
Attorney Dkt #:30481/52322P; 52322/US;PC
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor
1
Exec Dt:
07/16/2020
Assignee
1
C/O GENENTECH, INC.
1 DNA WAY
SOUTH SAN FRANCISCO, CALIFORNIA 94080
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
NONE
16966384
Correspondence name and address
MARSHALL, GERSTEIN & BORUN LLP
233 SOUTH WACKER DRIVE
6300 WILLIS TOWER
CHICAGO, IL 60606

Search Results as of: 09/22/2024 11:02 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT